brentuximab vedotin
takeda,seagen
['congrat', 'brentuximab', 'lymphoma', ' vedo', 'hodgkin']
congrats to at #ash2022 on prognostic significance of baseline mtv/pet2 with eshl, unfav risk, bulky tx bv-avd. 
Lymphoma specialist at Memorial Sloan Kettering Cancer Center and Medical Director of MSK Basking Ridge